BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21340522)

  • 1. Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy.
    Fischmann A; Gloor M; Fasler S; Haas T; Rodoni Wetzel R; Bieri O; Wetzel S; Heinimann K; Scheffler K; Fischer D
    J Neurol; 2011 Jul; 258(7):1333-40. PubMed ID: 21340522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy.
    Alonso-Jimenez A; Kroon RHMJM; Alejaldre-Monforte A; Nuñez-Peralta C; Horlings CGC; van Engelen BGM; Olivé M; González L; Verges-Gil E; Paradas C; Márquez C; Garibaldi M; Gallano P; Rodriguez MJ; Gonzalez-Quereda L; Dominguez Gonzalez C; Vissing J; Fornander F; Eisum AV; García-Sobrino T; Pardo J; García-Figueiras R; Muelas N; Vilchez JJ; Kapetanovic S; Tasca G; Monforte M; Ricci E; Gomez MT; Bevilacqua JA; Diaz-Jara J; Zamorano II; Carlier RY; Laforet P; Pelayo-Negro A; Ramos-Fransi A; Martínez A; Marini-Bettolo C; Straub V; Gutiérrez G; Stojkovic T; Martín MA; Morís G; Fernández-Torrón R; Lopez De Munaín A; Cortes-Vicente E; Querol L; Rojas-García R; Illa I; Diaz-Manera J
    J Neurol Neurosurg Psychiatry; 2019 May; 90(5):576-585. PubMed ID: 30530568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranuclear Aggregates Precede Clinical Onset in Oculopharyngeal Muscular Dystrophy.
    van der Sluijs BM; Raz V; Lammens M; van den Heuvel LP; Voermans NC; van Engelen BG
    J Neuromuscul Dis; 2016 Mar; 3(1):101-109. PubMed ID: 27854203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oculopharyngeal muscular dystrophy with limb girdle weakness as major complaint.
    Van Der Sluijs BM; Hoefsloot LH; Padberg GW; Van Der Maarel SM; Van Engelen BG
    J Neurol; 2003 Nov; 250(11):1307-12. PubMed ID: 14648146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative vs qualitative muscle MRI: Imaging biomarker in patients with Oculopharyngeal Muscular Dystrophy (OPMD).
    Melkus G; Sampaio ML; Smith IC; Rakhra KS; Bourque PR; Breiner A; Zwicker J; Lochmüller H; Brais B; Warman-Chardon J
    Neuromuscul Disord; 2023 Jan; 33(1):24-31. PubMed ID: 36462961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preferential distal muscle involvement in case of oculopharyngeal muscular dystrophy with (GCG) 13 expansion].
    Nakashima D; Nakajima H; Ishida S; Sugino M; Kimura F; Hanafusa T
    Rinsho Shinkeigaku; 2003 Sep; 43(9):560-3. PubMed ID: 14727564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Japanese case of oculopharyngeal muscular dystrophy (OPMD) with PABPN1 c.35G > C; p.Gly12Ala point mutation.
    Nishii YS; Noto YI; Yasuda R; Kitaoji T; Ashida S; Tanaka E; Minami N; Nishino I; Mizuno T
    BMC Neurol; 2021 Jul; 21(1):265. PubMed ID: 34225694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Between Quantitative MRI and Muscle Histopathology in Muscle Biopsies from Healthy Controls and Patients with IBM, FSHD and OPMD.
    Lassche S; Küsters B; Heerschap A; Schyns MVP; Ottenheijm CAC; Voermans NC; van Engelen BGM
    J Neuromuscul Dis; 2020; 7(4):495-504. PubMed ID: 32925090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oculopharyngeal muscular dystrophy: phenotypic and genotypic characteristics of 9 Polish patients.
    Nadaj-Pakleza A; Richard P; Lusakowska A; Gajewska J; Jamrozik Z; Kostera-Pruszczyk A; Kwieciński H; Kamińska A
    Neurol Neurochir Pol; 2009; 43(2):113-20. PubMed ID: 19484687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres.
    Trollet C; Anvar SY; Venema A; Hargreaves IP; Foster K; Vignaud A; Ferry A; Negroni E; Hourde C; Baraibar MA; 't Hoen PA; Davies JE; Rubinsztein DC; Heales SJ; Mouly V; van der Maarel SM; Butler-Browne G; Raz V; Dickson G
    Hum Mol Genet; 2010 Jun; 19(11):2191-207. PubMed ID: 20207626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of pelvic girdle and proximal leg muscles in early oculopharyngeal muscular dystrophy.
    van der Sluijs BM; Lassche S; Knuiman GJ; Kusters B; Heerschap A; Hopman M; Schreuder TH; van Engelen BGM; Voermans NC
    Neuromuscul Disord; 2017 Dec; 27(12):1099-1105. PubMed ID: 29102430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oculopharyngeal muscular dystrophy associated with dementia.
    Mizoi Y; Yamamoto T; Minami N; Ohkuma A; Nonaka I; Nishino I; Tamura N; Amano T; Araki N
    Intern Med; 2011; 50(20):2409-12. PubMed ID: 22001477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative MRI can detect subclinical disease progression in muscular dystrophy.
    Fischmann A; Hafner P; Fasler S; Gloor M; Bieri O; Studler U; Fischer D
    J Neurol; 2012 Aug; 259(8):1648-54. PubMed ID: 22297459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between physical symptoms and health-related quality of life in oculopharyngeal muscular dystrophy.
    Youssof S
    Muscle Nerve; 2016 May; 53(5):694-9. PubMed ID: 26453481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dropped-head in recessive oculopharyngeal muscular dystrophy.
    Garibaldi M; Pennisi EM; Bruttini M; Bizzarri V; Bucci E; Morino S; Talerico C; Stoppacciaro A; Renieri A; Antonini G
    Neuromuscul Disord; 2015 Nov; 25(11):869-72. PubMed ID: 26494409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of fat infiltration in oculopharyngeal muscular dystrophy: comparison of three MR imaging methods.
    Gloor M; Fasler S; Fischmann A; Haas T; Bieri O; Heinimann K; Wetzel SG; Scheffler K; Fischer D
    J Magn Reson Imaging; 2011 Jan; 33(1):203-10. PubMed ID: 21182140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of the muscle involvement along the disease progression in a large cohort of oculopharyngodistal myopathy compared to oculopharyngeal muscular dystrophy.
    Eura N; Noguchi S; Ogasawara M; Kumutpongpanich T; Hayashi S; Nishino I;
    J Neurol; 2023 Dec; 270(12):5988-5998. PubMed ID: 37634163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy.
    Hino H; Araki K; Uyama E; Takeya M; Araki M; Yoshinobu K; Miike K; Kawazoe Y; Maeda Y; Uchino M; Yamamura K
    Hum Mol Genet; 2004 Jan; 13(2):181-90. PubMed ID: 14645203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle MRI in Patients With Oculopharyngeal Muscular Dystrophy: A Longitudinal Study.
    Kroon RHMJM; Kalf JG; de Swart BJM; Heskamp L; de Rooy JWJ; van Engelen BGM; Horlings CGC
    Neurology; 2024 Jan; 102(1):e207833. PubMed ID: 38165364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Siblings with recessive oculopharyngeal muscular dystrophy.
    Hebbar S; Webberley MJ; Lunt P; Robinson DO
    Neuromuscul Disord; 2007 Mar; 17(3):254-7. PubMed ID: 17296297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.